Skip to main content Skip to section navigation Skip to footer
Bringing science to life News Careers Contact us
Immunocore Holdings plc
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Our Values
    • Compliance and Transparency
  • Pipeline & Portfolio
    • Pipeline
    • Our Therapies
  • Science
    • Overview
    • Publications
    • Human Leukocyte Antigen System
  • Clinical Trials
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • Financials & Filings
    • Governance
    • IR Resources
  • Medical Information
    • Request medical information
    • US healthcare professionals
    • UK healthcare professionals
    • Grants and funding
  • Bringing science to life
  • News
  • Careers
  • Contact us

Events

Investors

Investors

  • Overview
  • News
    • Press Releases
    • Email Alerts
  • Events & Presentations
    • Events
    • Presentations
  • Stock Info
    • Quote and Chart
    • Historical Performance
    • Analyst Coverage
  • Financials & Filings
    • Financial Results
    • SEC Filings
    • Annual Reports
    • Email Alerts
  • Governance
    • Overview
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contacts

  • Events & Presentations

  • Events
  • Presentations

Q4 2025 Earnings Call

Feb 25, 2026 8:00 am EDT
Earnings Release
HTML PDF
Earnings Webcast
Audio
Presentation
PDF
10-K Filing
HTML PDF
XBRL
ZIP
  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
Immunocore Holdings plc
  • Visit us on Linkedin
  • Visit us on Youtube
©2026 Immunocore Holdings plc. All Rights Reserved.
Disclaimer Sitemap Compliance and Transparency Terms and Conditions
Privacy and Social Media Guidelines Cookies Payments and Disclosures Tax Policy Statement
Clinical Trials Gender Pay Gap Report Modern Slavery Statement

This is Immunocore's global website, intended for visitors seeking information on Immunocore's worldwide business.

If you are a medical professional and would like further information about Immunocore, our clinical research or clinical trials, please send an email to medical.information@immunocore.com (US) or medinfo.eu@immunocore.com (outside of US).

CM-GL-TAX-2400001
Date of production: April 2024